Cargando…
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
BACKGROUND: A previous phase 3 trial of prucalopride in pediatric patients (6 months–18 years old) with functional constipation (FC) demonstrated no efficacy versus placebo. We designed an additional phase 3 trial to further assess the efficacy, long-term safety and tolerability of prucalopride in c...
Autores principales: | Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192401/ https://www.ncbi.nlm.nih.gov/pubmed/37215389 http://dx.doi.org/10.1016/j.conctc.2023.101144 |
Ejemplares similares
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015) -
A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
por: Tack, Jan, et al.
Publicado: (2023) -
Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
por: Ke, M, et al.
Publicado: (2012) -
Effect of prucalopride on symptoms of chronic constipation
por: Tack, J, et al.
Publicado: (2013) -
Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation
por: Tameez Ud Din, Asim, et al.
Publicado: (2019)